$0.23

+0.00 (+0.73%)

Weekly Expected Move ±6.3%

$0 $0 $0 $0 $0

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $246.3M mcap · 836M float · 0.086% daily turnover · Short 27% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

Income Trends

Revenue

$149M +77.1% ▲

5Y CAGR: +42.4%

Gross Profit

$73M +83.3% ▲

5Y CAGR: +44.0%

Operating Income

$50M +154.9% ▲

5Y CAGR: +88.4%

Net Income

$45M +1140.0% ▲

5Y CAGR: +54.6%

EPS (Diluted)

$0.03 +912.5% ▲

5Y CAGR: +43.2%

EBITDA

$52M +1728.6% ▲

5Y CAGR: +70.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$32M	$34.2B	$57M	$84M	$149M
YoY Growth	+27.1%	+105767.6%	-99.8%	+48.4%	+77.1%
Cost of Revenue	$17M	$17.6B	$30M	$44M	$75M
Gross Profit	$15M	$16.6B	$26M	$40M	$73M
Gross Margin	45.9%	48.6%	46.5%	47.7%	49.4%
R&D Expenses	$4M	$6.2B	$7M	$8M	$5.7B
SG&A Expenses	$4M	$5.1B	$7M	$9M	$17.6B
Operating Expenses	$10M	$12.9B	$16M	$20M	$24M
Operating Income	$5M	$2.0B	$11M	$20M	$50M
Operating Margin	15.7%	5.9%	19.1%	23.3%	33.6%
Interest Expense	$192K	$1M	$589K	$772K	$397K
Income Before Tax	$7M	$4.0B	$463K	-$52K	$57M
Tax Expense	-$2M	-$424M	-$20M	$4M	$12M
Net Income	$9M	$4.4B	$20M	-$4M	$45M
Net Margin	27.6%	12.9%	35.5%	-5.1%	30.1%
EPS (Diluted)	$0.01	$4.35	$0.02	$-0.00	$0.03
EBITDA	$6M	$6M	$3M	$3M	$52M
Shares Outstanding	1.01B	1.01B	1.02B	1.07B	1.14B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$19M	$19M	$14M	$32M	$40M	$36M	$32M	$41M
Cost of Revenue	$10M	$11M	$8M	$15M	$13M	$22M	$19M	$20M
Gross Profit	$8M	$8M	$6M	$17M	$27M	$14M	$13M	$20M
Gross Margin	45.1%	43.4%	42.6%	54.1%	67.7%	38.7%	41.0%	50.1%
R&D Expenses	$2M	$2M	$2M	$2M	$2M	$1M	$1M	$2M
SG&A Expenses	$2M	$2M	$3M	$2M	$3M	$4M	$2M	$8M
Operating Expenses	$4M	$5M	$5M	$6M	$6M	$6M	$4M	$9M
Operating Income	$4M	$3M	$1M	$11M	$22M	$8M	$9M	$11M
Operating Margin	20.6%	18.5%	7.6%	34.9%	54.0%	22.6%	28.5%	27.1%
Interest Expense	$251K	$255K	$78K	$189K	$159K	$82K	$80K	$75K
Income Before Tax	$848K	-$10M	-$11M	$19M	-$564K	$16M	$21M	$21M
Tax Expense	$232K	$2M	$239K	$2M	$5M	$2M	$2M	$2M
Net Income	$616K	-$11M	-$11M	$17M	-$6M	$14M	$19M	$18M
Net Margin	3.3%	-58.5%	-75.8%	53.1%	-14.6%	37.7%	58.9%	45.3%
EPS (Diluted)	$0.00	$-0.01	$-0.01	$0.02	$-0.01	$0.01	$0.01	$0.02
EBITDA	$2M	-$9M	-$10M	$20M	$103K	$16M	$10M	$12M
Shares Outstanding	1.08B	1.07B	1.07B	1.07B	1.07B	1.14B	1.14B	1.08B

ELTP OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet